2,5-Morpholinedione, 6-methyl-3-(3-methylbutyl)-4-[(1S)-1-phenylethyl]-,(3S,6R)- (833489-44-4)

Identification
Name:	2,5-Morpholinedione, 6-methyl-3-(3-methylbutyl)-4-[(1S)-1-phenylethyl]-,(3S,6R)-
CAS:	833489-44-4
Molecular Formula:	C₁₈H₂₅NO₃
Molecular Structure:
Properties
Safety Data

Other Product

2,5-Morpholinedione, 3-(2E)-2-butenyl-6-methyl-4-[(1S)-1-phenylethyl]-,(3S,6R)-
2,5-Morpholinedione, 6-methyl-4-[(1S)-1-phenylethyl]-, (6R)-
2,5-Morpholinedione,4-methyl-6-(1-methylethyl)- 3-(phenylmethyl)-,(3S,6R)-
2,5-Morpholinedione, 6-methyl-4-[(1S)-1-phenylethyl]-, (6S)-
2,5-Morpholinedione,6-ethyl-3-methyl-, (3S)-
2,5-Morpholinedione,6-methyl-3-(1-methylethyl)-,(3S)-(9CI)
2,5-Morpholinedione, 6-methyl-3-(2-methylpropyl)-, (3S,6S)-
2,5-Morpholinedione,4-methyl-3,6-bis(1-methylethyl)-, (3S,6R)-
2,5-Morpholinedione,3-methyl-, (3S)-
2,5-Morpholinedione,4-methyl-6-(1-methylethyl)-3-(phenylmethyl)-
2-Butenoicacid, 4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-ylester, (2E)-
2-Butenoic acid,4-[(2-hydroxy-5-oxo-1-cyclopenten-1-yl)amino]-4-oxo-,(2R,4R,5S,6R)-tetrahydro-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-2-methoxy-5-methyl-6-(1-methylethyl)-2H-pyran-4-ylester, (2E)-
2,5-Morpholinedione, 6-methyl-3-(phenylmethyl)-, (3S,6S)-
2-Butenoic acid,4-amino-4-oxo-,(2R,4R,5S,6R)-6-ethyltetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14E)-10-hydroxy-3-methoxy-7,9,11,13,15-pentamethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-2H-pyran-4-ylester, (2E)- (9CI)
2-Butenedioic acid(2E)-,1-[(2R,4R,5S,6R)-tetrahydro-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-2-methoxy-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl]ester
2-Butenedioic acid(2E)-,1-[(2R,4R,5S,6R)-tetrahydro-2-hydroxy-2-[(1S,2R,3S)-2-hydroxy-3-[(2R,3S,4E,6E,9S,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxooxacyclohexadeca-4,6,12,14-tetraen-2-yl]-1-methylbutyl]-5-methyl-6-(1-methylethyl)-2H-pyran-4-yl]ester
Oxacyclohexadeca-3,5,11,13-tetraen-2-one,16-[(1S,2R,3S)-3-[(2R,4R,5S,6R)-4-[(6-deoxy-2-O-methyl-a-L-mannopyranosyl)oxy]tetrahydro-2-hydroxy-5-methyl-6-(1-methylethyl)-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-8-hydroxy-3,15-dimethoxy-5,7,9,11-tetramethyl-,(3Z,5E,7R,8S,9S,11E,13E,15S,16R)- (9CI)
2,5-Morpholinedione,3-(1-methylethyl)-, (3S)-
3-Piperidinol, 4-methyl-1-[(1S)-1-phenylethyl]-, (3S,4R)-
7-Oxabicyclo[4.1.0]heptan-2-one, 3-methyl-6-(1-methylethyl)-,(1S,3S,6R)-